Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7138505 Factor VIII:C nucleic acid molecules

Patent 7138505 was granted and assigned to Novartis on November, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Rae Lyn Burke0

Carol Pachl0

Daniel Caput0

Frank Masiarz0

George Kuo0

Martha Truett0

Mirella Ezban Rasmussen0

Pablo Valenzuela0

Date of Patent

November 21, 2006

0

Patent Application Number

075693760

Date Filed

August 13, 1990

0

Patent Citations Received

US Patent 12071456 Extended recombinant polypeptides and compositions comprising same

0

US Patent 11685771 Recombinant factor VIII proteins

0

US Patent 12018046 Use of cation-exchange chromatography in the flow-through mode to enrich post-translational modifications

0

Patent Primary Examiner

0

Patent abstract

Methods and compositions are provided for recombinant DNA production of Factor VIIIC and truncated derivatives thereof. Based on amino acid sequences, probes are developed for isolating messenger RNA, cDNA and/or chromosomal DNA encoding for Factor VIIIC. The Factor VIIIC gene in its entirety, a fragment thereof, or a cDNA is then used for expression of Factor VIIIC in a host.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7138505 Factor VIII:C nucleic acid molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool